https://medicine.ouhsc.edu/directory Parent Page: Directory id: 22535 Active Page: Detailsid:23325

Directory

Categories

Nelson Iván Agudelo Higuita MD, DTM&H, CTH®
Internal Medicine

Nelson Iván Agudelo Higuita, MD, DTM&H, CTH®

Edith Kinney Gaylord Presidential Professor
Professor of Medicine
Program Director, Infectious Diseases Fellowship Program
Medical Lead of the University of Oklahoma Center for Travel and Immigrant Health


800 Stanton L. Young Blvd. 
AAT 7300
Oklahoma City, OK  73104

405-271-5882


Dr. Agudelo received his medical degree at the National Autonomous University of Honduras.  He completed both his Internal Medicine Residency and Infectious Diseases Fellowship at the University of Oklahoma Health Sciences Center.  He is currently the Program Director of the Infectious Diseases Fellowship Program, Medical Lead of the Infective Endocarditis Clinic and the University of Oklahoma Center for Travel and Immigrant Health.  He has special interest in reducing healthcare disparities in structurally vulnerable populations.


Academic Section(s):

Infectious Diseases


Education:

Medical School - MD:  Universidad Nacional Autónoma de Honduras


Board Certification(s):

Internal Medicine
Infectious Diseases


Residency:

Internal Medicine: University of Oklahoma Health Science Center


Fellowship:

Infectious Diseases: University of Oklahoma Health Science Center

Diploma in Tropical Medicine and Hygiene – Royal College of Physician of London


Clinical/Research Interests:

Reduction of Healthcare Disparities

Travel and Tropical Medicine

Immunocompromised Populations

Infective Endocarditis


Select Publications:

Migrants in transit across Central America and the potential spread of chloroquine resistant malaria–a call for action. The Lancet Regional Health - Americas 2023;22: 100505

Health inequities in the global response to the COVID-19 pandemic. Ther Adv Infect Dis. 2023 Apr 10;10:20499361231162726. doi: 10.1177/20499361231162726. eCollection 2023 Jan-Dec.

Burden of serious fungal infections in Honduras. Mycoses. 2022 Apr;65(4):429-439. doi: 10.1111/myc.13432. Epub 2022 Feb 23

Chagas Disease and Domestic Medical Screening Guidance for Newly Arrived Individuals Under a Humanitarian-Based Immigration Status: A Call for Action. Am J Trop Med Hyg. 2022 Nov 14;107(5):960-963

Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19. Cell Stress. 2021 Dec 21;6(1):6-16.

Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study. Sci Immunol. 2021 Aug 10;6(62):eabf3733.

Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis. ESC Heart Fail. 2021 Dec;8(6):5466-5481.

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study. EBioMedicine. 2022 Sep;83:104208

Chronic Chagas Disease-the Potential Role of Reinfections in Cardiomyopathy Pathogenesis. Curr Heart Fail Rep. 2022 Oct;19(5):279-289

Chagas disease in Oklahoma. Am J Med Sci. 2022 Nov;364(5):521-528

Rapid health evaluation in migrant peoples in transit through Darien, Panama: protocol for a multimethod qualitative and quantitative study. Ther Adv Infect Dis. 2021 Dec 15;8:20499361211066190